Showing posts with label reduce risk of cardiovascular death in adults with diabetes. Show all posts
Showing posts with label reduce risk of cardiovascular death in adults with diabetes. Show all posts
Wednesday, August 9, 2017

New drug receives FDA approval to reduce risk of cardiovascular death in adults with diabetes

›
The U.S. Food and Drug Administration today approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular d...